Clal Biotechnology Industries Ltd

A premier Israeli life sciences investment firm specializing in biotechnology, pharmaceuticals, diagnostics, and medical devices.

Venture Capital Tel Aviv, Israel Est. 1993
Visit website ↗ LinkedIn
Last updated 2026-10-29
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
Seed, Early Stage, Growth, Late Stage, Pre-clinical, Incubation, Start-up, Emerging Growth, Mid Venture, PIPES

About

Clal Biotechnology Industries (CBI) is a leading Israeli life sciences investment firm listed on the Tel Aviv Stock Exchange. CBI focuses on identifying and nurturing groundbreaking ventures that develop proprietary solutions to address unmet medical needs with substantial market potential. Its portfolio spans companies at various stages of growth, from seed to maturity, encompassing both private and publicly traded enterprises. CBI provides significant investments, hands-on leadership, and expert guidance to drive success.

Portfolio

No portfolio companies in this dataset yet.

Q&A

What is Clal Biotechnology Industries Ltd's primary investment focus?
Clal Biotechnology Industries Ltd (CBI) is a premier Israeli life sciences investment firm specializing in biotechnology, pharmaceuticals, diagnostics, and medical devices.
What is Clal Biotechnology Industries Ltd's investment thesis?
Clal Biotechnology Industries Ltd's thesis is identifying and supporting promising innovative ventures with proprietary solutions to unmet medical needs with multibillion-dollar market potential.
What investment stages does Clal Biotechnology Industries Ltd typically engage in?
Clal Biotechnology Industries Ltd invests across various stages, including Seed, Early Stage, Growth, Late Stage, Pre-clinical, Incubation, Start-up, Emerging Growth, Mid Venture, and PIPES.
What are the preferred geographic regions for Clal Biotechnology Industries Ltd's investments?
Clal Biotechnology Industries Ltd primarily focuses its investments in Israel and the United States.
What is the typical check size for Clal Biotechnology Industries Ltd's investments?
Clal Biotechnology Industries Ltd's typical check size ranges from $500,000 to $10,000,000 USD.
When was Clal Biotechnology Industries Ltd founded?
Clal Biotechnology Industries Ltd was founded in 1993.
Who is the CEO of Clal Biotechnology Industries Ltd?
Avi Fischer serves as the CEO of Clal Biotechnology Industries Ltd.
Who is the CFO of Clal Biotechnology Industries Ltd?
Liat Nissan is the CFO of Clal Biotechnology Industries Ltd.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)